A Complimentary Seminar: Innovations In Late Stage Drug Development: Reproductive Toxicology, Carcinogenicity, and the 3Rs
Wednesday, February 12 2014
11:30 am – 2:00 pm
This event was posted by Charles River Labs
Jessica Metterville (508.826.5488 or email@example.com)
Location: Hotel Marlowe 25 Edwin H. Land Blvd. Cambridge, Massachusetts 02141 USA
Charles River Presents: “Innovations in Late-Stage Drug Development: Reproductive Toxicology, Carcinogenicity and the 3Rs”
Charles River is pleased to invite you to a complimentary seminar exploring the innovations in the areas in late stage drug development. Discussions with the presenters and the group will enhance the participants’ understanding of the material.
The seminar will provide information regarding the advancements in a the use of alternative models for development and reproductive toxicology studies as well as proposed changes to ICH S1 guidelines.
The seminar will being at 11:30am and conclude at 2:00pm. Complimentary lunch will be provided for all attendees.
Topics to be presented are:
“Carcinogenicity Testing and Proposed Changes to ICH S1”
Mark A. Morse, PhD, DABT
Director of Research, Preclinical Services Ohio Charles River
“Alternative Models for Reproductive Toxicity Testing”
Alan M. Hoberman, PhD, DABT, Fellow ATS
Executive Director, Global Developmental, Reproductive and Juvenile Toxicology – Charles River